A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Product Line, Reimbursements and Corporate Structure Are In Full Swing

AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Product Line, Reimbursements and Corporate Structure Are In Full Swing

posted on Mar 18, 2022 03:02PM

Share
New Message
Please login to post a reply